-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- OnKure Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.69M, a 80.8% increase year-over-year.
- OnKure Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$41M, a 39.2% increase year-over-year.
- OnKure Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$77.4M, a 49% decline from 2022.
- OnKure Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$52M, a 30.6% decline from 2021.
- OnKure Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$39.8M, a 104% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)